Anti-TMED9 antibodies are used in the immunodetection of the protein transmembrane p24 trafficking protein 9. In humans, the canonical protein has a reported length of 235 amino acid residues and a mass of 27.3 kDa. Its subcellular localization is in the ER and Golgi. It is notably widely expressed in many tissue types. A member of the EMP24/GP25L protein family, TMED9 is suggested to be involved in vesicular protein trafficking, mainly in the early secretory pathway. Post-translational modifications have been described, including glycosylation. Synonyms for this target antigen include HSGP25L2G, p24a2, p24alpha2, p25, transmembrane emp24 domain-containing protein 9, and GMP25. TMED9 gene orthologs have been reported in the mouse, rat, frog, zebrafish and chimpanzee species. A number of TMED9 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Immunohistochemistry are also common applications.